Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for Pediatric Feeding Disorders
NCT02568007Phase 4Terminated
- Sponsor
- Medical College of Wisconsin
- Start
- Dec 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of cyproheptadine in Feeding and Eating Disorders (FED), failure to thrive (FTT), sponsored by Medical College of Wisconsin. Started Dec 2015; status: terminated.
02
Drugs
cyproheptadine
03
Conditions
Feeding and Eating Disorders (FED)failure to thrive (FTT)
Beyond the preview
Go deeper on NCT02568007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02568007.